AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-24267070_ITM" title="Facts and information about Geron to Present at Rodman & Renshaw 8th Annual Healthcare Conference.">Geron to Present at Rodman & Renshaw 8th Annual Healthcare Conference.</a>
Close
Set up an RSS feed that alerts you when new articles from Business Wire are available.
Frequently asked questions about RSS feeds
Geron to Present at Rodman & Renshaw 8th Annual Healthcare Conference.
MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN) will present an update of the company's product development programs at 8:30 a.m. EST on Wednesday, Nov. 8, 2006, at the Rodman & Renshaw 8th Annual Healthcare Conference in New York City.
The update of Geron's portfolio of telomerase-based anti-cancer therapies will include information about GRN163L and GRNVAC1. The presentation will also include reviews of the company's human embryonic stem cell programs in spinal cord injury (GRNOPC1), heart disease (GRNCM1), and diabetes (GRNIPC1). Thomas B. Okarma, Ph.D., M.D., Geron's president and chief executive officer, ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Geron Corporation to Present at Rodman & Renshaw Healthcare...
- Press release article from: Business Wire November 2, 2007 700+ words
MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN...Rodman & Renshaw 9th Annual Healthcare Conference in New York City...will include information about Geron's portfolio of anti-cancer...and for a period of 30 days. Geron is developing first-in...
- Geron Corporation to Present at Lazard Capital Markets Healthcare...
- Press release article from: Business Wire November 27, 2007 700+ words
MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN...Lazard Capital Markets 4th Annual Healthcare Conference in New York City...will include information about Geron's portfolio of anti-cancer...and for a period of 30 days. Geron is developing first-in...
- Geron Continues Aggressive Development of Embryonic Stem Cell Technology.
- Press release article from: Business Wire November 1, 2001 700+ words
...BW HealthWire)--Nov. 1, 2001 Geron Corporation (Nasdaq:GERN) today reaffirmed...commercializing embryonic stem cell technology. As Geron has previously described, the Wisconsin...WARF) has brought a lawsuit against Geron seeking a declaratory judgment concerning...
- Geron Files Motion in Lawsuit.
- Press release article from: Business Wire October 3, 2001 700+ words
...Calif.--(BW HealthWire)--Oct. 3, 2001 Geron Corporation (Nasdaq:GERN) announced today...Wisconsin Alumni Research Foundation ("WARF"). Geron's motion asks the court to rule in Geron's favor on the basis of WARF's amended complaint...
- Geron Announces Notice of Lawsuit.
- Press release article from: Business Wire August 14, 2001 700+ words
...BW HealthWire)--Aug. 13, 2001 Geron Corporation (Nasdaq:GERN) announced...Research Foundation ("WARF") advising Geron that WARF has filed a lawsuit seeking a declaratory judgment against Geron with respect to Geron's option to negotiate...
- Geron Corporation Adopts Share Purchase Rights Plan.
- Press release article from: Business Wire July 23, 2001 700+ words
...BW HealthWire)--July 23, 2001 Geron Corporation (Nasdaq:GERN) announced...Purchase Right on each outstanding share of Geron common stock. Subject to limited exceptions...person or group acquires 15% or more of Geron's common stock or announces a tender...
- Geron Corporation Makes Embryonic Stem Cell Protocols Available.
- Press release article from: Business Wire September 26, 2002 700+ words
...BUSINESS WIRE)--Sept. 26, 2002 Geron Corporation (Nasdaq:GERN) announced...that it has posted on its web site (www.geron.com) detailed protocols for scalable...undifferentiated human embryonic stem cells. Geron scientists developed the method for expanding...
- Geron Corporation Reports 2002 Third Quarter Results.
- Press release article from: Business Wire October 30, 2002 700+ words
...BUSINESS WIRE)--Oct. 30, 2002 Geron Corporation (Nasdaq:GERN) today reported...phase of the Kyowa Hakko collaboration. Geron expects to file an IND for the anti-cancer...for the drug in certain Asian countries. Geron otherwise holds all rights worldwide...
- Geron Announces Equity Issuance to Hong Kong Investors.
- Press release article from: Business Wire April 25, 2005 700+ words
MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN) announced today that it has sold shares of Geron common stock and issued warrants to purchase Geron common stock to prominent investors in Hong Kong for proceeds of $4 million. The shares...
- Geron Receives Favorable Ruling in Nuclear Transfer Patent Interference.
- Press release article from: Business Wire January 15, 2004 700+ words
...BUSINESS WIRE)--Jan. 15, 2004 Geron Corporation (Nasdaq:GERN) announced...patent interference proceeding between Geron and Infigen, Inc. of DeForest, Wisconsin...decision upholds the patentability of all of Geron's claims and finds all of the Infigen...
Source: HighBeam Research, Geron to Present at Rodman & Renshaw 8th Annual Healthcare...